(1)
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Fine-needle aspiration (FNA) is a safe, simple, rapid, and cost-effective procedure that allows the acquisition of samples not only from superficial and large lesions but also from small or deep-seated lesions. In addition, it allows for sampling multiple lesions during the same biopsy procedure. Therefore, FNA is often used as an initial diagnostic modality to work up metastatic tumors at almost any body site. It provides valuable information that enables clinicians and oncologists to evaluate patients’ prognosis and design optimal therapeutic strategies, including planning preoperative management for patients with operable tumors and choosing adequate medical therapy for patients with non-resectable tumors or hematopoietic malignancies.
To make a proper cytologic diagnosis, these key questions should be considered step by step:
Is the lesion neoplastic or nonneoplastic?
If it is neoplastic, is it benign or malignant?
If it is malignant, what is its cell lineage (i.e., epithelial, melanocytic, hematopoietic, or mesenchymal)?
In cases of epithelial malignancy (i.e., carcinoma), what is the subtype (e.g., adenocarcinoma, squamous carcinoma, neuroendocrine carcinoma, or others)?
If it is a malignant tumor, is it a primary tumor or a metastatic disease (regardless of its cell lineage)?
If it is a metastasis, what is its primary origin?
The main strategies used in an FNA diagnosis of metastatic malignancies are as follows:
Identifying cells that are “foreign” to the aspiration site to ensure a metastatic nature
Correlating FNA findings with a clinical history (i.e., previous malignancy and current presentation) and radiologic findings
Knowledge of the general metastatic pattern and morphologic pattern of various tumors
Using ancillary studies if necessary
Reviewing previous cytologic or surgical pathologic material and comparing morphologic features with those of the current lesion
Consulting experts if necessary
For insolvable cases, recommending tissue biopsy for histologic confirmation
This book provides a road map with which to navigate the thought process in reaching a proper final FNA diagnosis, with an emphasis on tumors in the metastatic setting. An algorithmic approach to FNA diagnosis (including the metastatic pattern, morphologic pattern, and immunophenotypic pattern) is outlined in Fig. 1.1 and will be expanded in subsequent chapters. Sample collection, triage, and recommendations for ancillary studies and molecular studies are covered as well.
Fig. 1.1
Algorithmic approach to fine-needle aspiration cytology diagnosis of metastatic tumors
Metastatic Pattern
Metastasis is one of the complicated biological properties of tumor cells. Usually, metastasis occurs in an orderly sequence: local invasion, breakthrough of the basement membrane, intravasation and survival in the blood or lymph stream, extravasation, colonization, and proliferation. Most metastases follow a predictable route of dissemination on the bases of the circulatory map. Locoregional metastasis usually occurs first, with a pattern corresponding to the blood or lymphatic drainage of the primary neoplasm; distant metastasis usually occurs later. The common destinations of distant metastases are the vascular organs, such as the liver, lungs, and brain. Bone is another preferential target of distant metastasis, although it is not a particularly vascular site. Notably, metastasis occurs more frequently in these organ sites than do primary tumors, and sometimes, metastatic tumors can cytologically resemble primary tumors of these sites. For example, adenocarcinoma of the pancreaticobiliary tract in the lungs often shows a bronchioloalveolar or “airway” growth pattern, mimicking primary bronchioloalveolar carcinoma of the lungs (Fig. 1.2).
Fig. 1.2
Metastatic pancreatic adenocarcinoma to the lung often shows “airway” growth pattern, resembling a primary mucinous bronchioloalveolar carcinoma (left, Papanicolaou stain; right, H&E-stained cell block)
In general, carcinomas tend to metastasize via the lymphatics and initially involve the lymph nodes, whereas sarcomas tend to metastasize hematogenously to visceral organs such as the liver and lungs. However, for gastrointestinal epithelial malignancies, the liver is the most common recipient due to the characteristic anatomic venous pathway. The common metastatic pattern of various tumors and the common primary origins of various metastatic sites are listed in decreasing frequency, on the basis of published studies, in Tables 1.1 and 1.2. Familiarity with the common metastatic pattern helps to predict the location of the primary tumor during the workup of FNA cases.
Table 1.1
Common metastatic sites of various malignancies
Primary origin of malignant tumor | Lymph node metastasis | Distant metastasis |
---|---|---|
Carcinoma | ||
Adrenal gland | Regional LNs | Liver, lung, bone |
Anorectal site | Inguinal, mesenteric LNs | Liver, lung |
Bladder | Pelvic, iliac, obturator, sacral, retroperitoneal LNs | Lung, liver, bone |
Breast | Axillary, internal mammary, supraclavicular, infraclavicular LNs | Bone, lung, liver, brain, adrenal gland, pleura (lobular CA may metastasize to GI and GYN sites, endocrine organs) |
Cervix | Pelvic, inguinal, retroperitoneal LNs | Lung, bowel |
Colorectal site | Regional LNs | Liver, lung, peritoneum |
Head and neck | Regional LNs, parotid gland | |
Esophagus | Regional LNs, supraclavicular LN | Liver, lung, peritoneum |
Kidney | LN metastasis is rare. Regional LNs | Lung, bone, liver, adrenal gland, brain, unusual sites (thyroid, small bone, others) |
Liver, hepatocellular CA | Regional LNs | Liver, lung, bone, adrenal gland |
Liver, cholangiocarcinoma | Regional LNs | Lung, bone, adrenal gland, peritoneum |
Lung | Hilar, mediastinal, supraclavicular LNs | Lung, adrenal gland, liver, bone, pleura, brain |
Ovary | Iliac, obturator, inguinal, pelvic, retroperitoneal LNs | Peritoneum, pleura, lung |
Pancreas | Regional LNs | Liver, peritoneum, lung (may mimic mucinous BAC) |
Parathyroid | Regional LNs | Lung, liver, bone |
Prostate | Pelvic, obturator, iliac, sacral, retroperitoneal, supraclavicular LNs | Bone (spine, femur, pelvis, rib), lung, liver, adrenal gland |
Gonadal or extragonadal sites (germ cell tumors) | Mediastinal LN, retroperitoneal LNs, supraclavicular LN | Lung (most common), liver brain, bone |
Thyroid | Regional LNs (usually for papillary and medullary CA) | Lung, bone, liver (for follicular and medullary CA) |
Salivary gland | Regional LNs, neck LNs | Lung |
Stomach | Regional LNs, left supraclavicular (Virchow) LN, periumbilical node (Sister Mary Joseph nodule) | Peritoneum, liver, ovary (Krukenberg tumor) |
Uterus | Pelvic, retroperitoneal LNs | Lung, peritoneum, vagina |
Melanoma | Regional LNs, distant LNs | Lung, liver, skin, soft tissue, adrenal gland, brain; intraocular melanoma exclusively metastasizes to liver |
Sarcoma
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |